Streamline Health Solutions (STRM) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Streamline Health Solutions in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" STRM shares.
View STRM analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued twelve-month price objectives for Streamline Health Solutions' stock. Their STRM share price forecasts range from $2.00 to $2.00. On average, they expect the company's stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 106.7% from the stock's current price.
View analysts price targets for STRM or view top-rated stocks among Wall Street analysts.

Streamline Health Solutions' stock was trading at $1.58 at the beginning of 2023. Since then, STRM stock has decreased by 38.8% and is now trading at $0.9675.
View the best growth stocks for 2023 here.

Streamline Health Solutions saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 50,200 shares, an increase of 59.4% from the August 31st total of 31,500 shares. Based on an average daily volume of 97,500 shares, the short-interest ratio is presently 0.5 days.
View Streamline Health Solutions' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 13th 2023.
View our STRM earnings forecast.

Streamline Health Solutions, Inc. (NASDAQ:STRM) posted its quarterly earnings data on Thursday, September, 14th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.02. The company had revenue of $5.77 million for the quarter. Streamline Health Solutions had a negative net margin of 44.61% and a negative trailing twelve-month return on equity of 32.09%.

31 employees have rated Streamline Health Solutions Chief Executive Officer David Sides on Glassdoor.com. David Sides has an approval rating of 82% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Streamline Health Solutions investors own include Energy Transfer (ET), CBL & Associates Properties (CBL), Garrison Capital (GARS), SandRidge Permian Trust (PER), BIOLASE (BIOL), Inovio Pharmaceuticals (INO), Martin Midstream Partners (MMLP), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX) and Aeterna Zentaris (AEZS).

Streamline Health Solutions trades on the NASDAQ under the ticker symbol "STRM."

Shares of STRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STRM stock can currently be purchased for approximately $0.97.

Streamline Health Solutions (NASDAQ:STRM) has a market capitalization of $56.99 million and generates $24.89 million in revenue each year. The company earns $-11,380,000.00 in net income (profit) each year or ($0.20) on an earnings per share basis.

The company employs 112 workers across the globe.

Streamline Health Solutions' mailing address is 11800 AMBER PARK DRIVE - SUITE 125, ALPHARETTA GA, 30009. The official website for the company is www.streamlinehealth.net. The company can be reached via phone at (888) 997-8732 or via email at randy.salisbury@streamlinehealth.net.